Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia

If you need an accessible version of this item, please submit a remediation request.
Date
2017-10-02
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
American Society for Clinical Investigation
Abstract

Juvenile myelomonocytic leukemia (JMML) is a pediatric myeloproliferative neoplasm that bears distinct characteristics associated with abnormal fetal development. JMML has been extensively modeled in mice expressing the oncogenic KrasG12D mutation. However, these models have struggled to recapitulate the defining features of JMML due to in utero lethality, nonhematopoietic expression, and the pervasive emergence of T cell acute lymphoblastic leukemia. Here, we have developed a model of JMML using mice that express KrasG12D in multipotent progenitor cells (Flt3Cre+ KrasG12D mice). These mice express KrasG12D in utero, are born at normal Mendelian ratios, develop hepatosplenomegaly, anemia, and thrombocytopenia, and succumb to a rapidly progressing and fully penetrant neonatal myeloid disease. Mutant mice have altered hematopoietic stem and progenitor cell populations in the BM and spleen that are hypersensitive to granulocyte macrophage-CSF due to hyperactive RAS/ERK signaling. Biased differentiation in these progenitors results in an expansion of neutrophils and DCs and a concomitant decrease in T lymphocytes. Flt3Cre+ KrasG12D fetal liver hematopoietic progenitors give rise to a myeloid disease upon transplantation. In summary, we describe a KrasG12D mouse model that reproducibly develops JMML-like disease. This model will prove useful for preclinical drug studies and for elucidating the developmental origins of pediatric neoplasms.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Tarnawsky, S. P., Kobayashi, M., Chan, R. J., & Yoder, M. C. (2017). Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia. Tarnawsky, S. P., Kobayashi, M., Chan, R. J., & Yoder, M. C. (2017). Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia. The Journal of Clinical Investigation, 127(10), 3652–3656. http://doi.org/10.1172/JCI94031, 127(10), 3652–3656. http://doi.org/10.1172/JCI94031
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Journal of Clinical Investigation
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}